United Therapeutics | UTHR - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Amarin USD 51.48M 113K 2025-12
Ardelyx USD 120.12M 14.46M 2025-12
Baxter International USD 6.04B 2.85B 2026-03
Bayer EUR 10.33B 126M 2025-12
BioCryst Pharmaceuticals USD 146.17M 534.06M 2025-12
Biogen USD 1.96B 69.6M 2026-03
BioMarin Pharmaceutical USD 636.56M 39.61M 2026-03
Emergent BioSolutions USD 555.9M 242.7M 2023-06
Esperion Therapeutics USD 83.21M 14.06M 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
Halozyme Therapeutics USD 211.07M 74.73M 2025-12
Insmed USD 513.55M 109.86M 2025-12
Ionis Pharmaceuticals USD 364M 54M 2026-03
J&J USD 17.44B 1.53B 2026-03
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
Moderna USD 1.78B 242M 2026-03
Omeros USD 59.16M 20.13M 2024-06
Pfizer USD 90.1B 77.19B 2026-03
PTC Therapeutics USD 246.3M 38.78M 2025-12
Regeneron Pharmaceuticals USD 31.42B 28.44B 2026-03
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sarepta Therapeutics USD 853.02M 390.78M 2025-12
Teva Pharmaceutical Industries USD 3.22B 1000M 2026-03
United Therapeutics USD 5.9B 5.1B 2026-03
Vertex Pharmaceuticals USD 1.85B 78.6M 2026-03